Regulatory Cosmetic News
Regulatory Cosmetic News Home Regulatory Cosmetic News Recent Blog Posts Follow Us on LinkedIn Want more cosmetic regulatory updates, industry insights, and practical tips? Follow…
Regulatory Cosmetic News Home Regulatory Cosmetic News Recent Blog Posts Follow Us on LinkedIn Want more cosmetic regulatory updates, industry insights, and practical tips? Follow…
Comprehensive Guide to South Africa Regulation Home Cosmetic Regulations South Africa Why Launch Your Cosmetics Brand in South Africa ? South Africa’s cosmetics market is…
In August 2024, Canada launched a PFAS data collection initiative under the Chemicals Management Plan. Companies handling listed PFAS in 2023 must report details—including quantities and product use—by January 29, 2025. Cosmetics and packaging containing PFAS may fall under the scope.
In the U.S., over-the-counter (OTC) drugs must include a standardized Drug Facts label—required by the FDA—to ensure clarity, safety, and informed consumer use. BIORIUS supports cosmetic and personal care brands by reviewing formulas and preparing compliant Drug Facts for various OTC categories, from sunscreen to oral care.
On June 24, 2024, the European Commission notified the “Omnibus VII” regulation to the WTO. Expected for adoption in Q3 2025, it bans two CMR-classified ingredients used in cosmetics—Dimethyltolylamine and TPO—from September 1, 2025. Products containing them must be removed from the EU market by this date.
May 2024: BIORIUS Information Letter 128: Update of the Canada Cosmetic Ingredient Hotlist Health Canada has updated the Canada Cosmetic Ingredient Hotlist. It includes…